Vitrectomy

Vitrectomy offers a viable therapeutic option for DMEMaurice B. Landers III, MD, presents an argument that in an era when pharmacological therapy has become the mainstay for the treatment of diabetic macular edema (DME), pars plana vitrectomy (PPV) deserves consideration as a reasonable alternative for early DME in appropriate patients.
Vitrectomy with brachytherapy shows no increase in metastatic riskThe metastatic prognosis does not increase when vitrectomy is performed at the time of brachytherapy.